Simultaneous detection of 45 fusion genes in leukemia by dual‐color fluorescence real‐time PCR

Abstract

Overall, we believe that this method is easily applicable, cost-effective, and clinically useful for a rapid screening of fusion genes in the initial diagnostic phase of leukemia. Its use can also be extended to the monitoring of minimal residual disease.